Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $256.4250 (0.28%) ($256.4250 - $256.4250) on Tue. Feb. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.25% (three month average) | RSI | 37 | Latest Price | $256.4250(0.28%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(46%) IBB(43%) SPLV(38%) DIA(35%) VYM(35%) | Factors Impacting UTHR price | UTHR will decline at least -0.625% in a week (0% probabilities). VXX(-21%) VIXM(-13%) UUP(-9%) TBT(-4%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.625% (StdDev 1.25%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $253.02(-1.33%) | Resistance Level | $256.67 | 5 Day Moving Average | $253.91(0.99%) | 10 Day Moving Average | $254.08(0.92%) | 20 Day Moving Average | $256.67(-0.1%) | To recent high | -8.5% | To recent low | 2.2% | Market Cap | $11.374b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |